Tsu, Japan

Masahiro Hasegawa


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovating Health: The Contributions of Masahiro Hasegawa

Introduction: Masahiro Hasegawa is a prominent inventor located in Tsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents, Hasegawa's work focuses on providing innovative solutions for medical diagnostics and treatments.

Latest Patents: Hasegawa's latest invention is titled “Monoclonal antibody and use thereof.” The objective of this invention is to provide an antibody that specifically recognizes the OPN N-half while avoiding recognition of the full-length OPN. This monoclonal antibody is characterized by its selective recognition of a protein or polypeptide with the C-terminal amino acid sequence YGLR (SEQ ID NO: 1). Furthermore, it does not recognize any variant of the amino acid sequence YGLR that is outside of the C-terminal. This invention extends beyond mere detection, as it includes methods for measuring OPN N-half, diagnosing related diseases, assessing disease severity, and ultimately tailoring treatments for such conditions.

Career Highlights: Within his career, Masahiro Hasegawa has been an integral part of Immuno-Biological Laboratories Co., Ltd., where he has contributed to multiple innovative projects that aim to improve healthcare outcomes. His dedication to research and development underscores the critical importance of biotechnological advancements.

Collaborations: Hasegawa has collaborated with colleagues such as Hiroko Kobayashi and Tsutomu Seito, who have also played important roles in research and development efforts at their company. This teamwork exemplifies the collaborative nature of scientific research and innovation in the biotechnology sector.

Conclusion: Masahiro Hasegawa's contributions to biotechnology through his patents reflect a commitment to addressing important health challenges. By developing targeted monoclonal antibodies, Hasegawa enhances the potential for precise disease diagnostics and therapies, paving the way for improved patient care. His innovations exemplify the remarkable impact that dedicated inventors can have on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…